Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CALCR | P30988 | 3/20 | 0.67 |
| ▸ | APLNR | P35414 | 2/20 | 0.65 |
| ▸ | GLP1R | P43220 | 8/20 | 0.64 |
| ▸ | GCGR | P47871 | 8/20 | 0.64 |
| ▸ | GIPR | P48546 | 5/20 | 0.61 |
| ▸ | F2 | P00734 | 2/20 | 0.60 |
| ▸ | TFPI | P10646 | 1/20 | 0.60 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.60 |
| ▸ | C5AR1 | P21730 | 1/20 | 0.60 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29963415 | 1.00 | CALCR (0.67) | CALCRAPLNRGLP1RGCGRGIPR | |
| SCHEMBL30276691 | 0.99 | CALCR (0.68) | CALCRAPLNRGLP1RGCGRF2 | |
| SCHEMBL30446021 | 0.98 | CALCR (0.68) | CALCRAPLNRGLP1RGCGRF2 | |
| SCHEMBL30185050 | 0.92 | APLNR (0.62) | CALCRAPLNRGLP1RGCGRF2 | |
| SCHEMBL31182915 | 0.91 | CALCR (0.72) | CALCRGLP1RGCGRGIPRF2 | |
| SCHEMBL31182794 | 0.91 | APLNR (0.64) | CALCRAPLNRGLP1RGCGRF2 | |
| SCHEMBL29446761 | 0.91 | APLNR (0.62) | CALCRAPLNRGLP1RGCGRF2 | |
| SCHEMBL30524357 | 0.90 | APLNR (0.67) | CALCRAPLNRGLP1RGCGRGIPR | |
| SCHEMBL30884870 | 0.90 | CALCR (0.75) | CALCRGLP1RGCGRGIPRKEAP1 | |
| SCHEMBL30358206 | 0.90 | CALCR (0.70) | CALCRAPLNRGLP1RGCGRTFPI |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115737833-B | Camptothecine polypeptide antitumor drug conjugate and preparation method and application thereof | 苏州久蓝生物医药有限公司 | 2025-06-13 | — | — | CN | claimed |
| US-20240207367-A1 | POLYPEPTIDE DRUG FOR PREVENTING AND/OR TREATING NEUROBLASTOMA AND USE THEREOF | ZHUHAI TENGBAI PHARMACEUTICAL CO LTD (CN) | 2024-06-27 | — | — | US | claimed |
| US-20230181696-A1 | POLYPEPTIDE DRUG FOR PREVENTING AND/OR TREATING NEUROBLASTOMA AND USE THEREOF | Zhuhai Tengbai Pharmaceutical Co., Ltd. (CN) | 2023-06-15 | — | — | US | claimed |
| CN-115737833-A | Camptothecin polypeptide antitumor drug conjugate and preparation method and application thereof | 苏州久蓝生物医药有限公司 | 2023-03-07 | — | — | CN | claimed |
| CN-115590972-A | Nano-gold-polypeptide composite drug-loading system and preparation method and application thereof | 苏州久蓝生物医药有限公司(CN) | 2023-01-13 | — | — | CN | claimed |
| CN-114222580-B | Polypeptide medicine for preventing and/or treating ovarian cancer and application thereof | 珠海市藤栢医药有限公司 | 2022-12-06 | — | — | CN | claimed |
| CN-114222753-A | Polypeptide medicine for preventing and/or treating neuroblastoma and application thereof | 珠海市藤栢医药有限公司 | 2022-03-22 | — | — | CN | claimed |
| CN-114222580-A | Polypeptide medicine for preventing and/or treating ovarian cancer and application thereof | 珠海市藤栢医药有限公司 | 2022-03-22 | — | — | CN | claimed |
| CN-115737833-B | Camptothecine polypeptide antitumor drug conjugate and preparation method and application thereof | 苏州久蓝生物医药有限公司 | 2025-06-13 | — | — | CN | disclosed |
| US-20240207367-A1 | POLYPEPTIDE DRUG FOR PREVENTING AND/OR TREATING NEUROBLASTOMA AND USE THEREOF | ZHUHAI TENGBAI PHARMACEUTICAL CO LTD (CN) | 2024-06-27 | — | — | US | disclosed |
| US-20230181696-A1 | POLYPEPTIDE DRUG FOR PREVENTING AND/OR TREATING NEUROBLASTOMA AND USE THEREOF | Zhuhai Tengbai Pharmaceutical Co., Ltd. (CN) | 2023-06-15 | — | — | US | disclosed |
| CN-115737833-A | Camptothecin polypeptide antitumor drug conjugate and preparation method and application thereof | 苏州久蓝生物医药有限公司 | 2023-03-07 | — | — | CN | disclosed |
| CN-115590972-A | Nano-gold-polypeptide composite drug-loading system and preparation method and application thereof | 苏州久蓝生物医药有限公司(CN) | 2023-01-13 | — | — | CN | disclosed |
| CN-114222580-B | Polypeptide medicine for preventing and/or treating ovarian cancer and application thereof | 珠海市藤栢医药有限公司 | 2022-12-06 | — | — | CN | disclosed |
| CN-114222580-B | Polypeptide medicine for preventing and/or treating ovarian cancer and application thereof | 珠海市藤栢医药有限公司 | 2022-12-06 | — | — | CN | disclosed |
| CN-114222753-A | Polypeptide medicine for preventing and/or treating neuroblastoma and application thereof | 珠海市藤栢医药有限公司 | 2022-03-22 | — | — | CN | disclosed |
| CN-114222580-A | Polypeptide medicine for preventing and/or treating ovarian cancer and application thereof | 珠海市藤栢医药有限公司 | 2022-03-22 | — | — | CN | disclosed |
| CN-114222580-A | Polypeptide medicine for preventing and/or treating ovarian cancer and application thereof | 珠海市藤栢医药有限公司 | 2022-03-22 | — | — | CN | disclosed |